On the other hand, neutralizing Spp1 in 5 × FAD mice reduced Aβ plaque deposition (Qiu et al. 2023), and increased SPP1 expression in MG was associated with faster cognitive decline in AD patients (Lopes et al. 2024). The gene discussed is SPP1; the disease is Alzheimer disease.